Search Within

1p lsd

Applied Filters:
Keyword:'1p lsd'
Showing 1-5 of 5 results for "1p lsd" within Papers
Christina Grumann et al.
Journal of pharmaceutical and biomedical analysis, 174, 270-276 (2019-06-11)
A variety of hallucinogens of the lysergamide type has emerged on the drug market in recent years and one such uncontrolled derivative of lysergic acid diethylamide (LSD) is 1-propionyl-LSD (1P-LSD). Due to the high potency of LSD and some of
Christina Grumann et al.
Drug testing and analysis, 12(8), 1144-1153 (2020-05-18)
1-Propanoyl-lysergic acid diethylamide (1P-LSD) appeared as a non-controlled alternative to LSD a few years ago. Although evidence is beginning to emerge from in vitro and animal studies that 1P-LSD might serve as a prodrug for LSD, an equivalent evaluation in
Adam L Halberstadt et al.
Neuropharmacology, 172, 107856-107856 (2019-11-23)
The ergoline d-lysergic acid diethylamide (LSD) is one of the most potent psychedelic drugs. 1-Acetyl-LSD (ALD-52), a derivative of LSD containing an acetyl group on the indole nitrogen, also produces psychedelic effects in humans and has about the same potency
Lea Wagmann et al.
Analytical and bioanalytical chemistry, 411(19), 4751-4763 (2019-01-09)
The market of new psychoactive substances (NPS) is characterized by a high turnover and thus provides several challenges for analytical toxicology. The analysis of urine samples often requires detailed knowledge about metabolism given that parent compounds either may be present
Simon D Brandt et al.
Drug testing and analysis, 11(8), 1122-1133 (2019-05-15)
The psychedelic properties of lysergic acid diethylamide (LSD) have captured the imagination of researchers for many years and its rediscovery as an important research tool is evidenced by its clinical use within neuroscientific and therapeutic settings. At the same time
Page 1 of 1